Single-cell RNA-SEQ (scrna-SEQ) technology

Ended Purchase Order Awarded Last action

Contract number
75N92021P00068
Awardee
Awarding agency
Obligated
$43,338

Award facts

Opportunity
  • 75N92021Q0055 Solicitation number
Contract value 100% obligated
$43,337.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
Total Small Business
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $43,337.50 for single-cell RNA-seq technology on February 10, 2021, with a total small business set-aside designation and performance completion by March 12, 2021. Work is performed in Pleasanton, California. The order is for firm fixed price supply of single-cell genomic analysis platforms, reagents, and related consumables supporting biomedical research.

Quick answers

Who was awarded contract 75N92021P00068?

75N92021P00068 was awarded to 10X Genomics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 10, 2021.

How much is contract 75N92021P00068 worth?

The government has obligated $43,338 on 75N92021P00068.

Was contract 75N92021P00068 competed?

The extent of competition for 75N92021P00068 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award